shares

Published: July 20, 2020 at 4:13 a.m. ET Shares of Enzymatica ENZY, +65.92% jumped 67% in Stockholm as the company said preliminary results show the ability of the mouth spray ColdZyme, in vitro, to deactivate SARS-CoV-2, the virus causing the COVID-19 pandemic. The study demonstrated that ColdZyme deactivates SARS-CoV-2 coronavirus by 98.3%, the company said.…

(Reuters) - Synairgen Plc (SYNG.L) said on Monday its drug helped reduce the risk of severe cases in hospitalised patients with COVID-19, according to data from a trial of more than 100 people in the United Kingdom, sending its shares skyrocketing. The trial, which used interferon beta, showed that patients who were given Synairgen’s formulation…

Moderna Inc.  (MRNA) - Get Report shares surged higher Wednesday after the drugmaker reported uniformly positive data from an early trial of its experimental coronavirus vaccine.Moderna said the phase 1 trial of MRNA-1273, its proposed coronavirus vaccine candidate, induced antibody reactions in all 45 patient participants, with no serious side-effects, following two injections spanning a four…

Moderna's shares soared after the company said its potential vaccine to prevent Covid-19 produced a "robust" immune response in all 45 patients in its early stage human trial, according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine.Moderna's stock rose more than 16% in after-hours trading on the news. All…

White House Social Media Director Dan Scavino. | Andrew Harnik/AP Photo President Donald Trump’s social media adviser posted a cartoon critical of Dr. Anthony Fauci on Facebook over the weekend, sharing the work of an artist who was barred from the White House last year for anti-Semitic imagery. Dan Scavino, the Trump administration's deputy chief…